“…Definition of FIRS with clinical and biomarker criteria has also been proposed [8]. FIRS is an independent risk factor for perinatal morbidity/mortality and is associated with long-term sequelae such as bronchopulmonary dysplasia and impaired neurological outcomes [1,2,3,4,5,6,7,8,9]. Although derangements in several biomarkers have been reported in umbilical cord blood of fetuses/neonates born to mothers with PPROM [9], prospective studies of diagnostic and prognostic markers of FIRS in neonates born to asymptomatic women with PPROM are lacking.…”